| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6018715 | Experimental Neurology | 2011 | 9 Pages |
Abstract
⺠New translational approach for IGF-I therapy in motoneuron diseases. ⺠Improved drug properties for IGF-I without loss of biological activity relevant for neuromuscular disorders. ⺠Systemic IGF-I exerts central neuroprotective effects on motoneurons. ⺠Neuroprotection correlates with functional benefits in pmn mice.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Sibylle Jablonka, Bettina Holtmann, Michael Sendtner, Friedrich Metzger,